Key result
ICD lead impedance changes correlate with serum potassium levels and can trigger audible hyperkalemia alerts.
Why the study?
The potential for implantable cardioverter-defibrillator lead impedance changes to detect acute hyperkalemia and trigger alerts was not well described.
Can implantable cardioverter-defibrillator lead impedance changes detect acute hyperkalemia?
Case Report (n=2)
Can implantable cardioverter-defibrillator lead impedance changes detect acute hyperkalemia?
Implantable cardioverter-defibrillator lead impedance monitoring may have a future role in detecting electrolyte abnormalities such as hyperkalemia.
Answers are grounded in this paper and cite their sources.
May not alter hyperkalemia monitoring; leaves open prospective validation of ICD impedance alerts.
Two cases of implantable cardioverter-defibrillator lead impedance changes that corresponded with changes in serum potassium are described. In the first case, an audible lead alert was triggered due to a significant change in lead impedance caused by hyperkalemia. In the second case, a patient was admitted with hyperkalemia and renal failure. Device interrogation revealed a change in lead impedance corresponding to changes in serum potassium. As devices and leads become more sophisticated, their role for monitoring parameters and triggering alerts may expand to include electrolyte and other metabolic changes.
No takes yet. Share an insight, caveat, or question.
Kuriachan et al. (2012) conducted a case report in Hyperkalemia (n=2). Implantable cardioverter-defibrillator lead impedance monitoring was evaluated on Lead impedance changes corresponding with changes in serum potassium. Implantable cardioverter-defibrillator lead impedance changes were observed to correspond with changes in serum potassium, triggering an audible alert in one case of hyperkalemia.
Synapse has enriched 10 related papers. Consider them for comparative context: